Cerba HealthCare announces that Philippe Buhl is leaving the company with effect from 1 February 2024
As part of the company governance changes, Cerba HealthCare announces that Philippe Buhl is leaving the company with effect from 1 February 2024.
He will no longer hold any corporate office within the Group, and in particular his position as Managing Director, which he has held since April 2023.
Philippe joined Cerba HealthCare in 2011.
Life science: Cerba HealthCare to acquire canadian contract research laboratory CIRION BioPharma Research to expand bioanalytical capabilities and shorten time-to-deploy complex clinical trials
Cerba HealthCare and Nexus Gulf Healthcare announce strategic joint venture to contribute to the upcoming transformation of healthcare system in Saudi Arabia
Cerba HealthCare changes its governance and appoints Emmanuel Ligner Group Chief Executive Officer
Cerba European Lab S.A.S. announces launch of offering of €355,000,000 senior secured
Saint-Ouen-L’Aumône, France — Monday 14 January 2013. Cerba European Lab S.A.S. (“Cerba European Lab”) today announced that it has launched an offering of €355,000,000 aggregate principal amount of its senior secured notes due...
Cerba European Lab S.A.S. commences consent solicitation for its 7.00% senior secured notes due 2020
Cerba European Lab S.A.S. (the “Issuer”) today announced the commencement of a solicitation (the “Solicitation”) of consents...
Consent solicitation for its 7% senior secured notes dues 2020
CERBA EUROPEAN LAB S.A.S. announces receipt of requisite consents in connection with the consent solicitation relating to its 7.00% senior secured notes due 2020 and execution of the supplemental indenture.
Cerba launch press release
CERBA EUROPEAN LAB S.A.S. announces launch of offering of €80 million in aggregate principal amount of 7.00% senior secured notes.
Cerba pricing press release
CERBA EUROPEAN LAB S.A.S. announces pricing of tap offering of senior secured notes.
Cerba European Lab continues its development in the South East of France
Clinical pathology group Cerba European Lab announces its takeover of JSBIO, a group of laboratories located in Bouches du Rhône, the Var, Vaucluse and Alpes Maritimes.